News & Articles
Selected Filters:
Sygnature Discovery invests £3m to expand high-throughput screening and translational oncology capabilities
Automated sample storage for multi-customer, multi-year storage HTS relationships
Nominate your favorite new lab product for a Scientists’ Choice Award: Nominations open today
Which new products made the most difference to your lab work this year?
Automation-enabled assay development for high throughput screening
Join us on Monday, September 21, to learn about assay development for high-throughput screening
Nitrosamine impurities: How LGC experts are protecting public health against carcinogens
Mike Ludlow explains the dangers associated with nitrosamines and how his team protects people from overexposure to possible carcinogens found in medications
Unraveling the complexity of protein interactions in the fight against neurodegenerative diseases
Learn how our understanding of neurodegenerative diseases has been transformed by affinity screening technology
SelectScience co-founder named top tech leader
Recognition comes as the publisher launches a series of Virtual Summits to support the science industry through the COVID-19 crisis
Revolutionizing early drug discovery for immuno-oncology and neurodegenerative disease modeling: High-throughput imaging of 3D models of disease
How Bioneer A/S is using state-of-the-art imaging technology to advance screening of 3D cancer spheroids and monitor neurite outgrowth
Achieving greater workflow efficiencies to improve assay development and screening
Watch this webinar to hear how SPT Labtech’s dragonfly discovery liquid handling platform has empowered the team at Merck
How LGC uses ICP-MS to overcome the challenges of elemental impurity testing in pharmaceutical products
Dr. Sarah Singh explains how her team works to protect public health by screening everything from tablets to e-cigarettes for up to 70 metals
How automated workflows can increase the capacity and scale of assay development and screening
Join this webinar to learn how you can implement the dragonfly discovery platform to improve the throughput and efficiency of your drug discovery process
The importance of the cellular microenvironment in the development of more efficient drugs against complex diseases
Learn about the 3D imaging technologies advancing phenotypic screening at HCS Pharma
GenScript releases Precision Mutant Library Services for drug development and synthetic biology
Services expedite downstream screening time with precision control and complete variant coverage
An accelerated discovery pipeline for antiviral antibody therapeutics
Watch this webinar to learn how researchers have implemented accelerated discovery and validation of potent therapeutic mAbs
IDT launches custom enrichment panels for faster and lower cost next-generation sequencing at ASHG 2019
Next-generation sequencing discovery pools enable larger custom panels and low sample numbers to speed up discovery
Measuring minimal residual disease related to cancer relapse with single cell genomics
Grant received to use the Mission Bio Tapestri Platform to improve the measurement of residual cancerous cells remaining post-treatment
Ultra-high-throughput screening (uHTS): How scientists at Scripps Research target global medical breakthroughs
From assay inception to dose response and medicinal chemistry, discover the cutting-edge technology used to identify small molecules with clinical potential, in this SelectScience interview
SLAS Europe 2019: the new technologies changing the future of drug discovery
Solutions for automation, assay development, high-throughput screening, imaging and more
Phagocytosis: Characterization of anti-CD47 Antibodies
How to Accelerate Nanobody Discovery Workflows with High-Throughput Flow Cytometry
Watch this on-demand webinar to learn how solutions from Sartorius are designed to increase the throughput of nanobody screening and discovery
Custom Genotyping Solution for Low- to High-Throughput Screening
New high-performance, cost-effective PACE SNP assays will lower the cost and improve the reliability of SNP or indel screening